Live feed
Filing
SC 13D/A
SC 13D/A0001144204-15-054654·Neurogene Inc.
Schedule 13D ownership disclosure
AQUINOX PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 03842B101
Event date: 2015-09-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,747,332
- Percent of class
- 39.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-054654
- Form type
- SC 13D/A
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Sep 11, 2015
- Reporting period
- Sep 10, 2015
- Description
- Schedule 13D beneficial ownership